Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Changes in Skin Color: Clinical Perspectives

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sleep Disturbance as a Mediator Between Itch and Quality of Life.

JAMA dermatology·2026

Same author

Epigenetic Modification in Preclinical and Clinical Dermatological Itch Conditions.

European journal of pain (London, England)·2026

Same author

Ethical considerations for managing psychogenic pruritus in patients with delusional parasitosis.

Journal of the American Academy of Dermatology·2026

Same author

Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study.

Dermatology and therapy·2026

Same author

Feasibility and Patient Experiences in a WhatsApp-Based Educational Pilot for Spanish-Speaking Adults With Chronic Spontaneous Urticaria.

International journal of dermatology·2026

Same author

Chronic Urticaria Part I: Clinical overview and molecular basis.

Journal of the American Academy of Dermatology·2026

Search research articles

Related Experiment Video

Updated: Jan 5, 2026

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

Skin changes in the obese patient.

Penelope A Hirt¹, David E Castillo¹, Gil Yosipovitch¹

¹Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.

Journal of the American Academy of Dermatology

|October 16, 2019

Summary

Obesity significantly impacts skin health, affecting its physiology, barrier function, and wound healing. Understanding these skin changes is crucial for diagnosing underlying disorders and improving patient outcomes.

Keywords:

acne atopic dermatitis epidermal barrier hidradenitis suppurativa obesity psoriasis rare skin diseases rosacea skin cancer skin changes skin infections tophaceous

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Related Experiment Videos

Last Updated: Jan 5, 2026

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Area of Science:

Dermatology
Public Health
Endocrinology

Background:

Obesity is a global health crisis with increasing prevalence.
The skin manifestations of obesity are often underestimated.
Increased body mass index (BMI) affects multiple skin functions.

Purpose of the Study:

To review the multifaceted effects of obesity on skin physiology and common dermatological conditions.
To highlight the association between obesity, metabolic disorders, and skin health.
To emphasize the importance of recognizing cutaneous signs for early diagnosis and management.

Main Methods:

Systematic review of literature on obesity and skin manifestations.
Analysis of how increased BMI impacts skin structure and function.
Compilation of common and rare skin conditions associated with obesity.

Main Results:

Obesity alters skin physiology, barrier function, collagen, and wound healing.
Common skin issues include acanthosis nigricans, striae distensae, and cellulite.
Obesity increases susceptibility to infections and exacerbates inflammatory dermatoses like hidradenitis suppurativa and psoriasis.

Conclusions:

Recognizing obesity-related skin signs aids in diagnosing systemic disorders.
Early identification of cutaneous manifestations can lead to better treatment and prevention of complications.
Further research is needed on the link between obesity, atopic dermatitis, and skin cancer risk.